Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes Therapy"
DOI: 10.1007/s13300-018-0426-0
Abstract: IntroductionThis study investigates the cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes mellitus in Serbia.MethodsA cost-utility analysis, implementing a simple short-term model, was used to compare… read more here.
Keywords: insulin; cost; glargine u100; cost effectiveness ... See more keywords
Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2019.1605769
Abstract: Abstract Objective: Type 2 diabetes (T2D) is associated with insulin resistance and deteriorated glycemic control that can be restored with insulin injections. Choice of insulin pen injector may affect complexity, adherence, efficacy of treatment and… read more here.
Keywords: insulin; pen injector; glargine u100; injector insulin ... See more keywords
Long-term cost-effectiveness analysis shows that IDegLira is associated with improved outcomes and lower costs compared with insulin glargine U100 plus insulin aspart in the US
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Medical Economics"
DOI: 10.1080/13696998.2018.1513406
Abstract: Abstract Aims: The clinical and economic impact of diabetes is growing in the US. Choosing therapies that are both effective and cost-effective is becoming increasingly important. The aim of the present analysis was to assess… read more here.
Keywords: plus insulin; glargine u100; insulin glargine; insulin aspart ... See more keywords
Efficacy and Safety of Insulin Icodec Versus Glargine U100: A Meta-Analysis of Randomized Controlled Trials.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of therapeutics"
DOI: 10.1097/mjt.0000000000001554
Abstract: Please view the PDF to see the formatted meeting abstract. read more here.
Keywords: icodec versus; safety insulin; versus glargine; insulin icodec ... See more keywords
Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes"
DOI: 10.1111/dom.14504
Abstract: To compare time in range (TIR) with use of insulin degludec U100 (degludec) versus insulin glargine U100 (glargine U100) in people with type 2 diabetes. read more here.
Keywords: insulin; time range; glargine u100; insulin degludec ... See more keywords
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of diabetes science and technology"
DOI: 10.1177/19322968221149041
Abstract: BACKGROUND Derived time in range (dTIR), calculated from self-monitored blood glucose (SMBG-dTIR) profiles, has demonstrated correlation with risk of cardiovascular and microvascular complications. This post hoc analysis of the DUAL V and DUAL VIII trials… read more here.
Keywords: dual viii; glargine u100; range; glargine ... See more keywords
Travelling Across Time Zones With Type 1 Diabetes: A Pilot Study Comparing Insulin Degludec With Insulin Glargine U100.
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes care"
DOI: 10.2337/dc21-1524
Abstract: OBJECTIVE For people with type 1 diabetes, there are limited evidence-based resources to support self-management when traveling across multiple time zones. Here, we compared glycemic control on insulin degludec versus glargine U100 as the basal… read more here.
Keywords: insulin; glargine u100; time; insulin degludec ... See more keywords